specificity testing of antibody and car-t cell therapies for ind using the membrane proteome array
Published 1 year ago • 134 plays • Length 1:02:08Download video MP4
Download video MP3
Similar videos
-
56:20
comprehensive specificity profiling of antibody-based therapeutics using the membrane proteome array
-
![[webinar]towards ind: specificity profiling of antibody therapies using the membrane proteome array](https://i.ytimg.com/vi/uycwUN0mPvY/mqdefault.jpg)
1:00:44
[webinar]towards ind: specificity profiling of antibody therapies using the membrane proteome array
-
59:03
webinar: redefining antibody specificity profiling for ind
-
2:37
membrane proteome array: de-risk your program by choosing the right lead molecule.
-
![[gen webinars] towards ind: specificity profiling of antibody-based therapies](https://i.ytimg.com/vi/RzMgxMnWksk/mqdefault.jpg)
1:12:23
[gen webinars] towards ind: specificity profiling of antibody-based therapies
-
56:58
translatable efficacy & safety testing of mab, bispecific, & car t therapies
-
2:21
car t-cell therapy: how does it work?
-
4:16
car t-cell therapy
-
13:10
car t cells: beating cancer with the immune system
-
1:32
car t cell therapy explained (animation) | city of hope
-
21:57
de-risking antibody lead selection: is your antibody as specific as you think? by ben doranz, phd
-
23:53
symposium | how to sequence car t-cell therapy and bispecific antibodies in r/r multiple myeloma
-
58:59
car-t cell therapy: current uses and future possibilities
-
1:00
side effects of car t cell therapy
-
3:14
car t-cell therapy explained (manufacturing process & how it works)
-
4:01
what are the differences between car t-cell therapy and bispecific antibodies?
-
1:45
evaluating nivolumab-based therapy to restore t-cell fitness in patients with r/r multiple myeloma
-
18:09
breast tumor-on-chip applicable for efficacy and safety assessment of car-t cell therapy